Teprotide

替普罗肽

Report date: 2022/05/20 15:26:07

Base Information

Drug NameTeprotide
Drug Alias NamePYR-WPRPQIPP血管舒缓激肽-增强肽 9ABPP 9A USP/EP/BP替普罗肽, ≥95% (TLC)Bradykinin potentiator BPP9a +[17
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension, Renovascular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertension, Renovascular

Other Information

ATC CodeN/A
Related LinksN/A